| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a8e3139b20ac12b32716359fc568d29 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2001-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f8d97922204750cc290086fb4d279f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d9bc7256bab1621704b9c7d71b0c6d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e1e6c34848a72af94dd8b9f0447106d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96012659a4a997990e7b6f8a949ed4f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7adcab726513000693a7227ca2681ffc |
| publicationDate |
2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1307245-B1 |
| titleOfInvention |
Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter |
| abstract |
The invention concerns a pharmaceutical form comprising a support material and at least a cell regulating factor and/or a cell proliferation promoter, preferably a growth factor. The invention is characterised in that the support material consists, for at least 90 wt. % of a composition based on methylidene malonate containing 0 to 10 wt. % of one or several methylidene malonate of formula (I) wherein: A and B independently represent a group (a) or (b) wherein R1 and R2 independently represent a C1-C6 linear or branched alkyl group, and n is an integer ranging between 1 and 5; 10 to 90 wt. %, preferably 50 to 90 wt. % of one or several methylidene malonate oligomer(s) having a molecular weight not more than 6000 and consisting of repeat units of formula (II) wherein A and B are such as defined above; 10 to 90 wt. %, preferably 10 to 50 wt. % of one or several methylidene malonate polymer(s) having a molecular weight more than 6000 and consisting of repeat units of formula (II). Said pharmaceutical form is useful for treating skin lesions. |
| priorityDate |
2000-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |